Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Maximize Value

Developing strategies to accelerate the shift from volume to value

Out-of-Industry Lessons for Healthcare Leaders

Healthcare leaders have much to learn from the retail and aviation industries in their journey to transparency.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Retail and CPG, Oliver Wyman
Partner, Consumer and Industrials, Oliver Wyman

Part One: In Recovery Mode

We're entering the Great Unknown regarding health insurance enrollment mix.

Partner, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman

When redesigning their workplaces, leaders must reflect on employees' best interests, versus their own.

Global Head, Health Services, Oliver Wyman
Partner, Financial Services, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Digital, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Organizational Effectiveness & Transformation, Oliver Wyman

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

With bid season approaching, payers' pharmacy teams must re-evaluate how to competitively position themselves for success.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Insights in your inbox

Subscribe

While many partnerships fail to deliver real economic value, here's how one CEO broke through.

CEO, UW Health
Partner, Health and Life Sciences, Oliver Wyman

Let the Survival of the Fittest Begin

How healthcare leaders can better understand what makes their businesses tick amid factors they can’t control.  

Principal, Health and Life Sciences, Oliver Wyman
Partner, Financial Services, Oliver Wyman

Summary of CY2022 Advance Notice Summary Part II

CMS proposes Stars rating changes, revises MA plan definitions, calls for new COVID-19 vaccination measures, and more.

Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman

The nation's new "normal" may not come until Q4 of 2021. Companies must consider what is sustainable and where to adjust for the long haul.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

How extended periods of suppressed utilization and a regulatory pause on record collection may influence plans' anticipated results next year.

Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Advisor, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe